000 | 01912 a2200589 4500 | ||
---|---|---|---|
005 | 20250517110734.0 | ||
264 | 0 | _c20180116 | |
008 | 201801s 0 0 eng d | ||
022 | _a1949-2553 | ||
024 | 7 |
_a10.18632/oncotarget.10892 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZechner, Dietmar | |
245 | 0 | 0 |
_aIntratumoral heterogeneity of the therapeutical response to gemcitabine and metformin. _h[electronic resource] |
260 |
_bOncotarget _cAug 2016 |
||
300 |
_a56395-56407 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAdenocarcinoma _xblood |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
650 | 0 | 4 | _aBlood Glucose |
650 | 0 | 4 | _aCell Hypoxia |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 | _aCoculture Techniques |
650 | 0 | 4 |
_aDeoxycytidine _xanalogs & derivatives |
650 | 0 | 4 | _aDrug Resistance, Neoplasm |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHydrogen-Ion Concentration |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMetformin _xpharmacology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aPancreatic Neoplasms _xblood |
650 | 0 | 4 | _aPancreatic Stellate Cells |
650 | 0 | 4 |
_aTumor Burden _xdrug effects |
650 | 0 | 4 | _aTumor Microenvironment |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
650 | 0 | 4 | _aGemcitabine |
700 | 1 | _aBürtin, Florian | |
700 | 1 | _aAlbert, Ann-Christin | |
700 | 1 | _aZhang, Xianbin | |
700 | 1 | _aKumstel, Simone | |
700 | 1 | _aSchönrogge, Maria | |
700 | 1 | _aGraffunder, Josefine | |
700 | 1 | _aShih, Hao-Yu | |
700 | 1 | _aMüller, Sarah | |
700 | 1 | _aRadecke, Tobias | |
700 | 1 | _aJaster, Robert | |
700 | 1 | _aVollmar, Brigitte | |
773 | 0 |
_tOncotarget _gvol. 7 _gno. 35 _gp. 56395-56407 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.10892 _zAvailable from publisher's website |
999 |
_c26292996 _d26292996 |